Skip to content
Open access

Estimated glucose disposal rate outperforms other insulin resistance indices for cardiometabolic multimorbidity prediction in CKM syndrome stages 0–3

Aug 2026 · Scientific Reports · 0 citations

TL;DR

Among individuals with CKM stages 0–3, all five insulin resistance indices were independently associated with incident CMM, with eGDR demonstrating superior incremental predictive value in this cohort, suggesting that eGDR may serve as a promising surrogate marker for risk stratification in this population, pending further validation.

Abstract

Cardiovascular-kidney-metabolic (CKM) syndrome is a potential public health challenge characterized by overlapping cardiovascular, kidney, and metabolic disorders. Although insulin resistance-related surrogate indices have been linked to cardiometabolic outcomes, their prognostic value for incidence of cardiometabolic multimorbidity (CMM) among individuals with CKM syndrome remains unclear. This prospective cohort study used data from the China Health and Retirement Longitudinal Study between 2011 and 2020. A total of 7,237 participants with CKM stages 0–3 were included. Associations of five insulin resistance-related indices with incident cardiometabolic multimorbidity were assessed using Cox proportional hazards models, restricted cubic spline analyses, and Kaplan–Meier methods. The predictive performance of the five indices was compared using time-dependent receiver operating characteristic curves, net reclassification improvement, and integrated discrimination improvement. Additionally, joint and mediation analyses were performed to evaluate the mediating role of C-reactive protein. Over a median follow-up of 9 years, 703 participants (9.7%) developed CMM. In fully adjusted models, eGDR was inversely associated with incident CMM, whereas METS-IR, TyG, LAP, and TG/HDL-C were positively associated, with corresponding HRs for the highest versus lowest quartiles of 0.13, 2.86, 2.81, 2.99, and 1.99, respectively (all P  < 0.001). RCS analyses demonstrated linear associations for eGDR and TyG and nonlinear associations for METS-IR, LAP, and TG/HDL-C. Among the five indices, eGDR showed the strongest incremental predictive value for CMM beyond the baseline model, with significant improvements in NRI and IDI (all P  < 0.01). Joint analyses showed that low eGDR combined with elevated CRP levels was associated with the highest risk of CMM, whereas mediation analyses suggested a statistically significant but quantitatively modest mediating role of CRP (2.6%). Among individuals with CKM stages 0–3, all five insulin resistance indices were independently associated with incident CMM, with eGDR demonstrating superior incremental predictive value in this cohort. The coexistence of low eGDR and elevated CRP identified individuals at particularly high risk. Our findings suggest that eGDR may serve as a promising surrogate marker for risk stratification in this population, pending further validation.

Read PDF

Similar papers

Open access Sep 2026

Estimated glucose disposal rate shows the broadest associations with cardiometabolic multimorbidity progression in early cardiovascular–kidney–metabolic stages: a longitudinal cohort study

Background Early risk stratification may help prevent cardiometabolic multimorbidity (CMM) among adults at cardiovascular–kidney–metabolic (CKM) stages 0–3. We compared the estimated glucose disposal rate (eGDR), triglyceride–glucose (TyG) index, and atherogenic index of plasma (AIP) for incident CMM, disease transitio...

Zun-Wei Wang, Yan-Yan Liu, Yi-Tong Ling et al. · 0 citations
Review Open access Sep 2026

Evaluative performance of triglyceride-glucose-frailty index versus surrogate insulin resistance indices for advanced cardiovascular-kidney-metabolic syndrome, cardiometabolic multimorbidity, and mortality: the role of estimated glomerular filtration rate

TyG-FI, which captures both metabolic dysfunction and physiological frailty, showed stronger associations with advanced CKM syndrome, prevalent CMM, and mortality than most surrogate insulin resistance indices, and may offer a pragmatic tool for early mortality risk stratification in individuals with high cardiometabol...

Kang Liu, Jia-Yuan Zhang, Hui He et al. · 0 citations
Review Open access Sep 2026

Insulin resistance and uric acid-related metabolic disturbances jointly identify individuals at high risk of advanced cardiovascular-kidney-metabolic syndrome: a population-based study

Higher TyG and SUA levels, particularly their co-occurrence, were associated with prevalent advanced CKM, suggesting these biomarkers may characterize distinct but overlapping metabolic profiles relevant to CKM assessment.

Sheng-Zhu Huang, Jing-Wei Lin, Ling-Yu Ye et al. · 0 citations
Review Open access Aug 2026

Reassessment-stage metabolic indices and subsequent cardiorenal outcomes in adults with diabetes: CHARLS and an independent hospital validation cohort

Among adults with diabetes identified in 2011 who returned for the 2015 CHARLS reassessment and remained free of overt cardiorenal outcomes, higher TyG, TCBI, and METS-IR were associated with subsequent composite cardiorenal outcomes.

Ming-Liang Liu, Yan Kong, Shi-Hang Chen et al. · 0 citations
Open access Oct 2026

Association of Combined Cardiometabolic and Muscle Impairment Index with Cardiovascular-Kidney-Metabolic Syndrome Progression Among Middle-Aged and Older Adults: A Prospective Two-Cohort Study

Introduction: Advanced cardiovascular-kidney-metabolic (CKM) syndrome portends poor cardiovascular outcomes. The cardiometabolic index (CMI) and muscle-loss index (MLI) independently reflect metabolic and cardiovascular risk, but their combined effect on CKM syndrome remains unexplored. We aimed to evaluate the associa...

Zi-Shun Liu, Xiao-Ying Ren, Chang Su et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.